Skip to main content
Erschienen in: BMC Surgery 1/2022

Open Access 01.12.2022 | Case report

Splenic infarction after Epstein–Barr virus infection in a patient with hereditary spherocytosis: a case report and literature review

verfasst von: Zhongwu Ma, Zhejin Wang, Xiaodan Zhang, Haibo Yu

Erschienen in: BMC Surgery | Ausgabe 1/2022

Abstract

Background

Hereditary spherocytosis (HS) complicated by splenic infarction is very rare, and it is even rarer to develop splenic infarction after infectious mononucleosis (IM) as a result of Epstein–Barr virus (EBV) infection. Therefore, misdiagnosis or missed diagnosis is prone to occur.

Case presentation

A 19-year-old Chinese female previously diagnosed with HS was admitted to our institution with persistent high fever and icterus. On admission, the physical examination showed anemia, jaundice, marked splenomegaly, obvious tenderness in the left upper abdomen (LUA). Peripheral blood film shows that spherical red blood cells accounted for about 6%, and Immunoglobulin M (IgM) antibodies specific to Epstein–Barr virus (EBV) viral capsid antigen were detected. An abdominal CT scan revealed a splenic infarction. The patient was diagnosed with HS with splenic infarction following EBV infection and underwent an emergency laparoscopic splenectomy (LS). Pathological analysis showed a splenic infarction with red pulp expansion, white pulp atrophy and a splenic sinus filled with red blood cells. After two months of follow-up visits, the patient showed no signs of relapse.

Conclusions

HS complicated by splenic infarction is very rare and mostly occurs in men under 20 years of age and is often accompanied by other diseases, such as sickle cell traits (SCT) or IM. Although symptomatic management may be sufficient, emergency laparoscopic splenectomy may be safe and effective when conservative treatment is ineffective.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
HS
Hereditary spherocytosis
IM
Infectious mononucleosis;
EBV
Epstein–Barr virus
LUA
Left upper abdomen
IgM
Immunoglobulin M
CT
Computed tomography
LS
Laparoscopic splenectomy
SCT
Sickle cell traits
WBC
White blood cells
RBC
Red blood cells
Hb
Hemoglobin
HCT
Hematocrit
Rct
Reticulocyte
PLT
Platelet
TBIL
Total bilirubin
IBIL
Indirect bilirubin
ALT
Alanine aminotransferase
AST
Aspartate aminotransferase
LDH
Lactate dehydrogenase
CPK
Creatine phosphokinase
CRP
C-reactive protein
PCT
Procalcitonin
G6PD
Glucose-6-phosphate dehydrogenase
BRT
Blood routine

Background

Hereditary spherocytosis (HS) is a heterogeneous hereditary hemolytic anemia resulting from defects in genes encoding the red cell membrane skeleton [1]. The main clinical characteristics of HS include anemia, intermittent jaundice, splenomegaly and cholelithiasis. However, there is a notable heterogeneity in clinical characteristics with hemolytic anemia varying from mild to fulminant [2]. HS is characterized by the presence of spherocytes on the peripheral blood smear, which are formed by defects of erythrocyte membrane protein, such as spectrin and Ankyrin [1, 3]. The main cause of hemolysis in HS is the selective isolation and destruction of spherocytes in the spleen. Familial studies indicate that HS often arises due to autosomal dominant inheritance, accounting for about 75%.
Infectious mononucleosis (IM) is an acute self-limiting infectious disease caused by the Epstein–Barr virus (EBV) [4]. According to epidemiological surveys, EBV is estimated to affect more than 90% of the world's population [5]. Its main clinical features are fever, pharyngitis, lymphadenopathy, a significant increase in peripheral blood lymphocytes and abnormal lymphocytes, a positive heterophilic agglutination test, and the appearance of anti-EBV antibodies in the body after infection.
To our knowledge, the occurrence of splenic infarction in HS patients following EBV infection is quite rare. To this date, there is no literature available on cases that underwent emergency laparoscopic splenectomy(LS) as management. Herein, we report the case of an HS patient who developed a splenic infarction following an EBV infection, that was managed using emergency LS. Furthermore, a systematic review of this case was performed to offer more clinical insight and information.

Case presentation

A 19-year-old Chinese female was admitted to our institution with persistent high fever and icterus. Six months ago, she was diagnosed with HS due to icterus. HS had been diagnosed in her mother, and her symptoms, such as anemia after splenectomy, were significantly improved. One week ago, due to dizziness and fatigue, she was admitted to a local hospital for low hemoglobin (47 g/L). Red blood cell transfusion improved her anemia, with hemoglobin level rising to 62 g/L. However, symptoms of dizziness and fatigue did not alleviate. Two days ago, the patient developed fever and icterus and was admitted to our Hematology Department. On admission, physical examination findings were as follows: anemia, jaundice, marked splenomegaly, obvious tenderness in the left upper abdomen(LUA), and absence of lymphadenopathy.Laboratory tests revealed a WBC count of 3.9 × 109/L (lymphocytes 50.5%), an RBC count of 2.17 × 1012/L, a Hb concentration of 52 g/L, an HCT of 16.0%, an Rtc count of 5.8%, an atypical lymphocytes count of 7%, and a PLT count of 164 × 109/L. Peripheral blood film showed that spherical red blood cells accounted for about 6% (Fig. 1). Blood biochemical analysis was as follows: TBIL 5.3 mg/dL; IBIL 4.1 mg/dL; ALT 66 U/L; AST 65 U/L; LDH 958 U/L; CPK 55.9 U/L; ferritin 1344 ng/mL; CRP 145.9 mg/L; PCT 0.46 μg/L. Coagulation tests: D-dimer 717 ug/L; PT 12 s. The results of the Coombs tests were negative. Ham and sugar-water tests were faintly positive. The result of G6PD was normal. The osmotic fragility test showed that the osmotic fragility of erythrocytes increased overall. Autoimmune workup was negative. Paroxysmal nocturnal hemoglobinuria screened by flow cytometry was negative. Serologic test results revealed a positive EBV infection (EBV viral capsid antigen (EBV-VCA) IgM-positive, EBV-VCA IgG-positive, EBV nuclear antigen (EBNA) Ig G-positive, and EBV early antigen (EA) IgM-positive). Due to obvious tenderness in the LUA, a CT scan of the abdomen was performed, and it was found that the spleen was enlarged with multiple wedge-shaped low-density foci, suggesting the presence of splenic infarction (Fig. 2). Because of the poor effect of symptomatic and supportive treatment, emergency LS was performed. Intraoperatively, her spleen was obviously enlarged and presented with multiple large-area splenic infarcts (Fig. 3). Pustular lesions were also observed on the surface of the spleen. Pathology review demonstrated splenic infarction with red pulp expansion, white pulp atrophy, splenic sinus filled with red blood cells (Fig. 4). Unfortunately, the pathological evaluation of EBV in the resected spleen was not performed. Her operative and postoperative courses were uneventful. The patient recovered quickly after the operation and was discharged accordingly. BRT was made every 2 weeks after surgery. After two months of follow-up visits, the patient showed no relapse.

Discussion and conclusions

Splenic infarctions are seldom observed in HS. We searched for studies using PubMed Medline with a search strategy combining search terms and Medical Subject Headings (MeSH). The search strategy is as follows: (("Spherocytosis, Hereditary"[Mesh]) OR (Hereditary Spherocytoses[Title/Abstract])) AND (("Splenic Infarction"[Mesh]) OR ((((Splenic Infarction[Title/Abstract]) OR (Infarct of the Spleen[Title/Abstract])) OR (Splenic Infarct*[Title/Abstract])) OR (splenic sequestration[Title/Abstract]))). A total of 19 articles were obtained, 7 of which were excluded. A total of 13 cases with splenic infarction/sequestration associated with HS were selected, as shown in Table 1. Our research showed that HS combination splenic infarction was more common in male patients younger than 20 years old. Among these 13 patients, only 2 were patients older than 20 years [6, 7], and only 2 were female [8, 9]. The coexistence of HS and sickle cell traits(SCT) is unusual, but splenic infarction is far more likely to occur in such patients [7, 8, 1014]. The proposed mechanism is that the concentration of hemoglobin S in the spherocytes is higher; sickling might occur and cause decreased red cell deformability in the acidotic and hypoxic environment. As a result, a large number of cells are selectively retained in the sinusoids of the spleen and eventually induce infarction [7, 13, 14]. Thus, high altitude or airplane flights may induce splenic infarction in these patients [8, 11, 12]. Splenic infarction after EBV infection in HS patients is very rare, and currently, only 4 cases have been reported [9, 1517]. One reported case was that of a 13-year-old boy with coexisting protein C deficiency in addition to IM[15]. In these cases, the mechanism of splenic infarction was speculated to be due to insufficient blood and oxygen supply to the rapidly expanding spleen. Spherocytes are easily trapped in the splenic cord and removed by macrophages. During acute IM, proliferation and expansion of EBV-infected B-cells and activation of T-cells lead to the production of plenty of cytokines, resulting in rapid spleen enlargement [17]. Furthermore, EBV infection aggravates the hemolytic reaction, and the spleen rapidly enlarges to compensate, causing an insufficient oxygen supply to the parenchyma. The precise mechanism of splenic infarction remains elusive, and further case reports and studies are warranted.
Table 1
Summary of hereditary spherocytosis patients with splenic infarction: a literature review
Year of publication
Country
Age/sex
Underlying disease
Fever
Abdominal pain
Spleno- megaly
Splenic rupture
Splenectomy
Urgent/ selective
2007 [17]
Japan
10–20/M
IM
YES
LUA pain
YES
NO
YES
SEL
2015 [16]
United Kingdom
10–20/M
IM
YES
Left chest pain
YES
NO
NO
 
2020 [9]
USA
10–20/F
IM
YES
LUA pain
YES
NO
NO
 
2011 [10]
United Kingdom
10–20/M
SCT
NO
LUA pain
YES
NO
NO
 
2007 [8]
USA
10–20/F
SCT
NO
LUA pain
YES
NO
YES
URG
2003 [7]
USA
40–50/M
SCT
NO
LUA pain
YES
NO
NO
 
1997 [12]
France
10–20/M
SCT
YES
Left chest pain
N/A
NO
NO
 
1992 [14]
USA
0–10/M
SCT
NO
LUA pain
YES
NO
YES
SEL
1992 [14]
USA
10–20/M
SCT
NO
LUA pain
YES
NO
YES
SEL
1990 [13]
USA
10–20/M
SCT
YES
LUA pain
YES
NO
YES
SEL
2008 [15]
Germany
10–20/M
IM and PCD
YES
LUA pain
YES
NO
NO
 
2016 [6]
China
20–30/M
INS
YES
Left chest pain
YES
NO
YES
URG
2017 [18]
Swit
10–20/M
NO
NO
LUA pain
YES
NO
YES
URG
The present patient
China
10–20/F
IM
YES
LUA pain
YES
NO
YES
URG
IM Infectious mononucleosis, SCT Sickle cell traits, PCD Protein C deficiency, INS invasive nontyphoidal salmonellosis, LUA Left upper abdomen
According to the 2011 Guidelines on HS [3], the diagnosis of HS in our patient was definitive since our patient has a family history of HS, typical clinical features and laboratory investigations. Isolated splenic infarction can occur in the case of hematological malignancies, embolic diseases, splenic torsion, aortic dissection, vasculitis or vasospasm secondary to vasopressor therapy [15]. At present, there is only one reported case of a HS patient who underwent partial splenectomy due to a rare complication of secondary splenomegaly, traumatic splenic torsion, leading to splenic infarction [18]. In addition, some systemic infections are known to cause splenic infarction [6, 1921]. Reviewing previous literature about HS with concomitant splenic infarction, we found that some were accompanied by underlying prethrombotic disease SCT [7, 8, 1014], while others occurred following IM [9, 1517]. When splenic infarction occurs, the common clinical manifestation is left upper quadrant abdominal pain, and occasionally an atypical left chest pain may occur. When splenic infarction occurs in patients with coexisting HS and IM, in addition to the mentioned symptoms, there are often early manifestations of high fever, but no such manifestation was present in patients with coexisting HS and SCT. This is a point of identification. Our patient developed a high fever 5 days after her blood transfusion, followed by severe pain in the LUA, considering the occurrence of splenic infarction after EBV infection. Related laboratory examinations and abdominal CT scans confirmed our diagnosis. For this condition, most patients can be effectively relieved through conservative symptomatic and supportive treatment, and splenectomy may not be a necessary treatment [22].Our patient has undergone conservative treatment, including antibiotics,but the symptoms of high fever and abdominal pain have not improved. And there was a persistent increase in white blood cells, the highest white blood cell count reaches 19 × 109/L. After careful assessment of the risks and benefits, the patient underwent emergency laparoscopic splenectomy.We summarized previous reports and found that about 7 out of 13 HS patients with splenic infarction ultimately underwent splenectomy. Splenectomy is considered to be the most reliable and effective method for the treatment of HS. Although it cannot change the morphology of erythrocytes, it greatly reduces the destruction of erythrocytes and extends their lifespan, and symptoms such as anemia, jaundice, and reticulocyte levels are often significantly improved [1]. Previous literature reported on selective re-admission to the hospital for splenectomy due to concerns about the recurrence of splenic infarction [17]. Similarly, after carefully evaluating the risks and benefits, our patient underwent emergency LS. To our knowledge, there is no case report of emergency LS for HS complicated with splenic infarction. The operation was successful, and the patient recovered well. Hence, we believe that emergency laparoscopic splenectomy might be an effective and safe treatment. Nevertheless, further case reports and clinical research are warranted to substantiate our results.
In conclusion, we report a rare complication of splenic infarction in an HS patient following EBV infection. HS complicated by splenic infarction is very rare, mostly occurring in men under 20 years of age, and is more often than not accompanied by other diseases, such as SCT or IM. Symptomatic management may be sufficient; however, emergency laparoscopic splenectomy may be a safe and effective management strategy when conservative treatment is not effective.

Acknowledgements

We would like to express our gratitude to those who provided valuable advice.

Declarations

The study was approved on Wenzhou central Hospital ethical committee and informed consent was obtained from all individual participants included in the study.
Written consent was obtained from patient authorizing to publish their individual data or any accompanied figures in this manuscript.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet (London, England). 2008;372(9647):1411–26.CrossRef Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet (London, England). 2008;372(9647):1411–26.CrossRef
2.
Zurück zum Zitat Eber SW, Armbrust R, Schröter W. Variable clinical severity of hereditary spherocytosis: relation to erythrocytic spectrin concentration, osmotic fragility, and autohemolysis. J Pediatr. 1990;117(3):409–16.CrossRef Eber SW, Armbrust R, Schröter W. Variable clinical severity of hereditary spherocytosis: relation to erythrocytic spectrin concentration, osmotic fragility, and autohemolysis. J Pediatr. 1990;117(3):409–16.CrossRef
3.
Zurück zum Zitat Bolton-Maggs PHB, Langer JC, Iolascon A, Tittensor P, King M-J. Guidelines for the diagnosis and management of hereditary spherocytosis–2011 update. Br J Haematol. 2012;156(1):37–49.CrossRef Bolton-Maggs PHB, Langer JC, Iolascon A, Tittensor P, King M-J. Guidelines for the diagnosis and management of hereditary spherocytosis–2011 update. Br J Haematol. 2012;156(1):37–49.CrossRef
4.
Zurück zum Zitat Niederman JC, McCollum RW, Henle G, Henle W. Infectious mononucleosis Clinical manifestations in relation to EB virus antibodies. JAMA. 1968;203(3):205–9.CrossRef Niederman JC, McCollum RW, Henle G, Henle W. Infectious mononucleosis Clinical manifestations in relation to EB virus antibodies. JAMA. 1968;203(3):205–9.CrossRef
5.
Zurück zum Zitat Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update. Front Oncol. 2018;8:211.CrossRef Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update. Front Oncol. 2018;8:211.CrossRef
6.
Zurück zum Zitat Sridhar S, Lau SK, Woo PC. A diagnostic pitfall: salmonella splenic infarction in hereditary spherocytosis. Am J Med. 2016;129(1):42–3.CrossRef Sridhar S, Lau SK, Woo PC. A diagnostic pitfall: salmonella splenic infarction in hereditary spherocytosis. Am J Med. 2016;129(1):42–3.CrossRef
7.
Zurück zum Zitat Ustun C, Kutlar F, Holley L, Seigler M, Burgess R, Kutlar A. Interaction of sickle cell trait with hereditary spherocytosis: splenic infarcts and sequestration. Acta Haematol. 2003;109(1):46–9.CrossRef Ustun C, Kutlar F, Holley L, Seigler M, Burgess R, Kutlar A. Interaction of sickle cell trait with hereditary spherocytosis: splenic infarcts and sequestration. Acta Haematol. 2003;109(1):46–9.CrossRef
8.
Zurück zum Zitat Dulman RY, Buchanan GR, Ginsburg H, Fefferman NR, Greco MA, Borys D, Blei F. Splenic infarction due to concomitant hereditary spherocytosis and sickle cell trait. J Pediatr Surg. 2007;42(12):2129–31.CrossRef Dulman RY, Buchanan GR, Ginsburg H, Fefferman NR, Greco MA, Borys D, Blei F. Splenic infarction due to concomitant hereditary spherocytosis and sickle cell trait. J Pediatr Surg. 2007;42(12):2129–31.CrossRef
9.
Zurück zum Zitat Thida AM, Ilonzo I, Gohari P. Multiple splenic infarcts: unusual presentation of hereditary spherocytosis associated with acute Epstein-Barr virus infection. BMJ Case Rep. 2020;13:7.CrossRef Thida AM, Ilonzo I, Gohari P. Multiple splenic infarcts: unusual presentation of hereditary spherocytosis associated with acute Epstein-Barr virus infection. BMJ Case Rep. 2020;13:7.CrossRef
10.
Zurück zum Zitat Tso AC, Roper DR, Wong CL, Bain B, Layton DM. Splenic infarction in a patient with sickle cell trait and hereditary spherocytosis. Am J Hematol. 2011;86(8):695–6.CrossRef Tso AC, Roper DR, Wong CL, Bain B, Layton DM. Splenic infarction in a patient with sickle cell trait and hereditary spherocytosis. Am J Hematol. 2011;86(8):695–6.CrossRef
11.
Zurück zum Zitat Bronstein JA, Imbert P, Rapp C, Farret O. Sickle cell anemia A/S and hereditary spherocytosis revealed by a splenic infarction. Medecine tropicale : revue du Corps de sante colonial. 2003;63(6):639. Bronstein JA, Imbert P, Rapp C, Farret O. Sickle cell anemia A/S and hereditary spherocytosis revealed by a splenic infarction. Medecine tropicale : revue du Corps de sante colonial. 2003;63(6):639.
12.
Zurück zum Zitat Santiago J, Bonaimé V, Cheraitia Y, Robert R, Galacteros F. Splenic infarction revealing heterozygote sickle cell trait with spherocytosis. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 1997;4(12):1262–3.CrossRef Santiago J, Bonaimé V, Cheraitia Y, Robert R, Galacteros F. Splenic infarction revealing heterozygote sickle cell trait with spherocytosis. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 1997;4(12):1262–3.CrossRef
13.
Zurück zum Zitat Warkentin TE, Barr RD, Ali MA, Mohandas N. Recurrent acute splenic sequestration crisis due to interacting genetic defects: hemoglobin SC disease and hereditary spherocytosis. Blood. 1990;75(1):266–70.CrossRef Warkentin TE, Barr RD, Ali MA, Mohandas N. Recurrent acute splenic sequestration crisis due to interacting genetic defects: hemoglobin SC disease and hereditary spherocytosis. Blood. 1990;75(1):266–70.CrossRef
14.
Zurück zum Zitat Yang YM, Donnell C, Wilborn W, Goodman SR, Files B, Moore RB, Mohandas N, Mankad VN. Splenic sequestration associated with sickle cell trait and hereditary spherocytosis. Am J Hematol. 1992;40(2):110–6.CrossRef Yang YM, Donnell C, Wilborn W, Goodman SR, Files B, Moore RB, Mohandas N, Mankad VN. Splenic sequestration associated with sickle cell trait and hereditary spherocytosis. Am J Hematol. 1992;40(2):110–6.CrossRef
15.
Zurück zum Zitat Breuer C, Janssen G, Laws HJ, Schaper J, Mayatepek E, Schroten H, Tenenbaum T. Splenic infarction in a patient hereditary spherocytosis, protein C deficiency and acute infectious mononucleosis. Eur J Pediatr. 2008;167(12):1449–52.CrossRef Breuer C, Janssen G, Laws HJ, Schaper J, Mayatepek E, Schroten H, Tenenbaum T. Splenic infarction in a patient hereditary spherocytosis, protein C deficiency and acute infectious mononucleosis. Eur J Pediatr. 2008;167(12):1449–52.CrossRef
16.
Zurück zum Zitat Jones L, Refai Z, Linney M. An adolescent with hereditary spherocytosis who presented with splenic infarction. BMJ Case Rep. 2015;2015:1.CrossRef Jones L, Refai Z, Linney M. An adolescent with hereditary spherocytosis who presented with splenic infarction. BMJ Case Rep. 2015;2015:1.CrossRef
17.
Zurück zum Zitat Suzuki Y, Shichishima T, Mukae M, Ohsaka M, Hayama M, Horie R, Togano T, Miyazaki K, Ichinoe M, Iwabuchi K, et al. Splenic infarction after Epstein-Barr virus infection in a patient with hereditary spherocytosis. Int J Hematol. 2007;85(5):380–3.CrossRef Suzuki Y, Shichishima T, Mukae M, Ohsaka M, Hayama M, Horie R, Togano T, Miyazaki K, Ichinoe M, Iwabuchi K, et al. Splenic infarction after Epstein-Barr virus infection in a patient with hereditary spherocytosis. Int J Hematol. 2007;85(5):380–3.CrossRef
18.
Zurück zum Zitat Mett TR, Fischer H, Metzger J: [Longterm risk subtotal splenectomy?]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 2017, 88(4):339–341. Mett TR, Fischer H, Metzger J: [Longterm risk subtotal splenectomy?]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 2017, 88(4):339–341.
19.
Zurück zum Zitat Bitzer M, Armeanu S, Kröber SM, Horger MS, Erley CM. A young woman with splenic infarction. Lancet (London, England). 2003;362(9394):1456.CrossRef Bitzer M, Armeanu S, Kröber SM, Horger MS, Erley CM. A young woman with splenic infarction. Lancet (London, England). 2003;362(9394):1456.CrossRef
20.
Zurück zum Zitat Salgado F, Grana M, Ferrer V, Lara A, Fuentes T. Splenic infarction associated with acute Brucella mellitensis infection. Eur J Clin Microbiol Infect Dis. 2002;21(1):63–4.CrossRef Salgado F, Grana M, Ferrer V, Lara A, Fuentes T. Splenic infarction associated with acute Brucella mellitensis infection. Eur J Clin Microbiol Infect Dis. 2002;21(1):63–4.CrossRef
21.
Zurück zum Zitat Witmer CM, Steenhoff AP, Shah SS, Raffini LJ. Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: a new association? Pediatrics. 2007;119(1):e292–5.CrossRef Witmer CM, Steenhoff AP, Shah SS, Raffini LJ. Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: a new association? Pediatrics. 2007;119(1):e292–5.CrossRef
22.
Zurück zum Zitat Heo D-H, Baek D-Y, Oh S-M, Hwang J-H, Lee C-S, Hwang J-H. Splenic infarction associated with acute infectious mononucleosis due to Epstein-Barr virus infection. J Med Virol. 2017;89(2):332–6.CrossRef Heo D-H, Baek D-Y, Oh S-M, Hwang J-H, Lee C-S, Hwang J-H. Splenic infarction associated with acute infectious mononucleosis due to Epstein-Barr virus infection. J Med Virol. 2017;89(2):332–6.CrossRef
Metadaten
Titel
Splenic infarction after Epstein–Barr virus infection in a patient with hereditary spherocytosis: a case report and literature review
verfasst von
Zhongwu Ma
Zhejin Wang
Xiaodan Zhang
Haibo Yu
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Surgery / Ausgabe 1/2022
Elektronische ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-022-01580-5

Weitere Artikel der Ausgabe 1/2022

BMC Surgery 1/2022 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.